OSL Appendix 4E Preliminary Financial Report 30/08/24 PRICE SENSITIVE download Created with Sketch. 207.34KB Share OSL Successful Treatment with OncoSil Device in Turkiye 15/08/24 PRICE SENSITIVE download Created with Sketch. 149.09KB Share OSL Prospectus 07/08/24 PRICE SENSITIVE download Created with Sketch. 346.4KB Share OSL Quarterly Activities/Appendix 4C Cash Flow Report 31/07/24 PRICE SENSITIVE download Created with Sketch. 695.26KB Share OSL Australian institution to invest $2.7 million in OSL 25/07/24 PRICE SENSITIVE download Created with Sketch. 157.96KB Share OSL $5.3 million raised under Entitlement Offer 02/05/24 PRICE SENSITIVE download Created with Sketch. 164.95KB Share OSL 1st Study in Man Increases Pancreatic Tumor Vascularity 01/05/24 PRICE SENSITIVE download Created with Sketch. 183.01KB Share OSL Quarterly Activities/Appendix 4C Cash Flow Report 30/04/24 PRICE SENSITIVE download Created with Sketch. 385.2KB Share OSL First patient treated with OncoSil device in Turkiye 16/04/24 PRICE SENSITIVE download Created with Sketch. 200.86KB Share OSL First patient treated in the UK for the TRIPP-FXX study 12/04/24 PRICE SENSITIVE download Created with Sketch. 250.74KB Share OSL First Austria-based treatments utilising the OncoSil device 05/04/24 PRICE SENSITIVE download Created with Sketch. 360.47KB Share OSL Prospectus - Entitlement Offer 25/03/24 PRICE SENSITIVE download Created with Sketch. 687.2KB Share OSL Placement and Entitlement Offer to raise up to $7.1 million 20/03/24 PRICE SENSITIVE download Created with Sketch. 211.12KB Share OSL Trading Halt 18/03/24 PRICE SENSITIVE download Created with Sketch. 188.77KB Share OSL Appendix 4D and Half Year Accounts 28/02/24 PRICE SENSITIVE download Created with Sketch. 642.15KB Share OSL 84 German hospitals can negotiate fee for Oncosil device 01/02/24 PRICE SENSITIVE download Created with Sketch. 185.79KB Share OSL Quarterly Activities/Appendix 4C Cash Flow Report 31/01/24 PRICE SENSITIVE download Created with Sketch. 489.98KB Share OSL OncoSil receives $1.1m R&D tax incentive 15/12/23 PRICE SENSITIVE download Created with Sketch. 162.74KB Share OSL First two commercial patient treatments in Greece 08/12/23 PRICE SENSITIVE download Created with Sketch. 266.8KB Share OSL OncoSil onboards first patient in PANCOSIL Clinical Trial 29/11/23 PRICE SENSITIVE download Created with Sketch. 230.11KB Share OSL Quarterly Activities/Appendix 4C Cash Flow Report 30/10/23 PRICE SENSITIVE download Created with Sketch. 353.28KB Share OSL Appendix 4E and Annual Report 31/08/23 PRICE SENSITIVE download Created with Sketch. 2.22MB Share OSL Quarterly Activities/Appendix 4C Cash Flow Report 28/07/23 PRICE SENSITIVE download Created with Sketch. 356.23KB Share OSL Multi-Centre Data on OncoSil in Metastatic Pancreatic Cancer 30/06/23 PRICE SENSITIVE download Created with Sketch. 226.69KB Share OSL Ethics Committee Approves PANCOSIL Clinical Trial 05/06/23 PRICE SENSITIVE download Created with Sketch. 199.29KB Share OSL First patient treatment in Italy 22/05/23 PRICE SENSITIVE download Created with Sketch. 242.36KB Share OSL First patient enrolled in the TRIPP-FFX Clinical Study 03/05/23 PRICE SENSITIVE download Created with Sketch. 244.78KB Share OSL OncoSil to streamline operating structure 02/05/23 PRICE SENSITIVE download Created with Sketch. 212.96KB Share OSL First year anniversary of the OSPREY post-marketing registry 01/05/23 PRICE SENSITIVE download Created with Sketch. 247.44KB Share OSL Quarterly Activities/Appendix 4C Cash Flow Report 28/04/23 PRICE SENSITIVE download Created with Sketch. 499.43KB Share OSL Oral presentation at The Mayo Clinic IMPACT Course 24/04/23 PRICE SENSITIVE download Created with Sketch. 223.77KB Share OSL Further commercial milestones achieved in Spain 24/04/23 PRICE SENSITIVE download Created with Sketch. 224.69KB Share OSL Additional Binding Commitment Received for Entitlement Offer 21/04/23 PRICE SENSITIVE download Created with Sketch. 209.05KB Share OSL Non-renounceable Rights Issue Offer Prospectus 20/03/23 PRICE SENSITIVE download Created with Sketch. 819.31KB Share OSL Commitment received for Offer and updated Timetable 17/03/23 PRICE SENSITIVE download Created with Sketch. 199.79KB Share OSL Entitlement Offer Presentation 17/03/23 PRICE SENSITIVE download Created with Sketch. 982.7KB Share OSL Entitlement Offer to raise up to $9.9 million 17/03/23 PRICE SENSITIVE download Created with Sketch. 284.84KB Share OSL Half-Yearly Report Results 28/02/23 PRICE SENSITIVE download Created with Sketch. 279.79KB Share OSL Half Yearly Report and Accounts 28/02/23 PRICE SENSITIVE download Created with Sketch. 662.75KB Share OSL Quarterly Activities/Appendix 4C Cash Flow Report 31/01/23 PRICE SENSITIVE download Created with Sketch. 484.51KB Share OSL Two key treatment centres treat first patients with OncoSil 31/01/23 PRICE SENSITIVE download Created with Sketch. 197.49KB Share OSL OncoSil achieves milestone of 10 patients treated in Spain 15/12/22 PRICE SENSITIVE download Created with Sketch. 193.65KB Share OSL Distribution agreement signed for selected Chinese markets 14/12/22 PRICE SENSITIVE download Created with Sketch. 199.85KB Share OSL Quarterly Activities/Appendix 4C Cash Flow Report 31/10/22 PRICE SENSITIVE download Created with Sketch. 490.66KB Share OSL 2022 AGM CEO Presentation 25/10/22 PRICE SENSITIVE download Created with Sketch. 1.08MB Share OSL OncoSil Receives $832k R&D Tax Incentive 24/10/22 PRICE SENSITIVE download Created with Sketch. 200.03KB Share OSL OncoSil to Present at South-West Connect ASX Showcase 18/10/22 PRICE SENSITIVE download Created with Sketch. 1.18MB Share OSL Appendix 4E Announcement 31/08/22 PRICE SENSITIVE download Created with Sketch. 266.82KB Share OSL Appendix 4E and Annual Report 31/08/22 PRICE SENSITIVE download Created with Sketch. 2.7MB Share OSL Investor Presentation 03/08/22 PRICE SENSITIVE download Created with Sketch. 1.04MB Share OSL Monthly Activities/Appendix 4C Cash Flow Report 29/07/22 PRICE SENSITIVE download Created with Sketch. 496.75KB Share OSL Patient treated in Spain proceeds to successful resection 19/07/22 PRICE SENSITIVE download Created with Sketch. 213.08KB Share OSL Bupa UK Approves Reimbursement for OncoSil in the UK 04/07/22 PRICE SENSITIVE download Created with Sketch. 209.93KB Share OSL FY 2023 Strategic Update 30/06/22 PRICE SENSITIVE download Created with Sketch. 217.74KB Share OSL OncoSil PanCO Clinical Trial Presented At ESMO World WCGIC 29/06/22 PRICE SENSITIVE download Created with Sketch. 199.7KB Share OSL Entitlement Offer Results and Shortfall Notification 09/06/22 PRICE SENSITIVE download Created with Sketch. 201.99KB Share OSL Trading Halt 08/06/22 PRICE SENSITIVE download Created with Sketch. 210.38KB Share OSL OncoSil Entitlement Offer Booklet 10/05/22 PRICE SENSITIVE download Created with Sketch. 361.97KB Share OSL Clarification Of Non-Renouncable Entitlement Offer Details 02/05/22 PRICE SENSITIVE download Created with Sketch. 846.52KB Share OSL Investor Presentation 29/04/22 PRICE SENSITIVE download Created with Sketch. 734.02KB Share OSL OncoSil Launches $10m Capital Raising 29/04/22 PRICE SENSITIVE download Created with Sketch. 282.3KB Share OSL Quarterly Activities/Appendix 4C Cash Flow Report 29/04/22 PRICE SENSITIVE download Created with Sketch. 867.87KB Share OSL OncoSil Signs Commercial Agreement With Hospital In Spain 29/04/22 PRICE SENSITIVE download Created with Sketch. 220.58KB Share OSL Trading Halt 27/04/22 PRICE SENSITIVE download Created with Sketch. 207.12KB Share OSL First Commerical Pancreas Treatment In Spain 13/04/22 PRICE SENSITIVE download Created with Sketch. 214.12KB Share OSL Fully-Funded Trial Approved In Germany 28/03/22 PRICE SENSITIVE download Created with Sketch. 218.59KB Share OSL Half Yearly Report Results 22/02/22 PRICE SENSITIVE download Created with Sketch. 283.27KB Share OSL Half Yearly Report and Accounts 22/02/22 PRICE SENSITIVE download Created with Sketch. 674.09KB Share OSL OncoSil approved for Innovation Funding (NUB) in Germany 03/02/22 PRICE SENSITIVE download Created with Sketch. 211.91KB Share OSL Quarterly Activities/Appendix 4C Cash Flow Report 31/01/22 PRICE SENSITIVE download Created with Sketch. 478.63KB Share OSL PanCO Clinical Study on OncoSil Published in ESMO Open 24/12/21 PRICE SENSITIVE download Created with Sketch. 267.36KB Share OSL Quarterly Activities/Appendix 4C Cash Flow Report 29/10/21 PRICE SENSITIVE download Created with Sketch. 476.61KB Share OSL 2021 AGM CEO Presentation 19/10/21 PRICE SENSITIVE download Created with Sketch. 802.36KB Share OSL 2021 AGM Chairman's Address 19/10/21 PRICE SENSITIVE download Created with Sketch. 315.98KB Share OSL Receipt of $1.077m R&D Tax Incentive Refund 27/09/21 PRICE SENSITIVE download Created with Sketch. 203.32KB Share OSL Appendix 4E Announcement 19/08/21 PRICE SENSITIVE download Created with Sketch. 284.85KB Share OSL Appendix 4E and Annual Report 19/08/21 PRICE SENSITIVE download Created with Sketch. 1.13MB Share OSL Quarterly Activities/Appendix 4C Cash Flow Report 26/07/21 PRICE SENSITIVE download Created with Sketch. 496.52KB Share OSL OncoSil TGA regulatory update 02/06/21 PRICE SENSITIVE download Created with Sketch. 255.86KB Share OSL OncoSil receives regulatory approval from Hong Kong 04/05/21 PRICE SENSITIVE download Created with Sketch. 215.63KB Share OSL Appendix 4C - quarterly 29/04/21 PRICE SENSITIVE download Created with Sketch. 492.86KB Share OSL Half Yearly Report and Accounts 23/02/21 PRICE SENSITIVE download Created with Sketch. 415.31KB Share OSL Half-Yearly Report Results 23/02/21 PRICE SENSITIVE download Created with Sketch. 290.47KB Share OSL OncoSil Investor Update 18/02/21 PRICE SENSITIVE download Created with Sketch. 1.15MB Share OSL Appendix 4C - quarterly 28/01/21 PRICE SENSITIVE download Created with Sketch. 491.37KB Share OSL Appointment of Chief Executive Officer 21/01/21 PRICE SENSITIVE download Created with Sketch. 273.13KB Share OSL OncoSil FY21 half yearly review 18/01/21 PRICE SENSITIVE download Created with Sketch. 245.86KB Share OSL Termination of Mr Daniel Kenny as Chief Executive Officer 02/12/20 PRICE SENSITIVE download Created with Sketch. 210.14KB Share OSL OncoSil receives Swiss regulatory approval 05/11/20 PRICE SENSITIVE download Created with Sketch. 220.13KB Share OSL OncoSil achieves first commercial sale 22/10/20 PRICE SENSITIVE download Created with Sketch. 302.82KB Share OSL Appendix 4C - quarterly 21/10/20 PRICE SENSITIVE download Created with Sketch. 506.86KB Share OSL Positive PanCO trial update on resected cohort 20/10/20 PRICE SENSITIVE download Created with Sketch. 319.8KB Share OSL 2020 AGM CEO Presentation 20/10/20 PRICE SENSITIVE download Created with Sketch. 984.59KB Share OSL Receipt of $2.8m R&D Tax Incentive Refund 23/09/20 PRICE SENSITIVE download Created with Sketch. 208.4KB Share OSL Investor Update 28/08/20 PRICE SENSITIVE download Created with Sketch. 1.34MB Share OSL OncoSil receives Malaysian regulatory approval 28/08/20 PRICE SENSITIVE download Created with Sketch. 264.36KB Share OSL Preliminary Final Report - Appendix 4E Announcement 19/08/20 PRICE SENSITIVE download Created with Sketch. 286.58KB Share OSL Appendix 4E and Annual Report 19/08/20 PRICE SENSITIVE download Created with Sketch. 3.13MB Share OSL Appendix 4C - quarterly 30/07/20 PRICE SENSITIVE download Created with Sketch. 507.9KB Share OSL HDE filing submitted in US for Bile Duct Cancer treatment 28/07/20 PRICE SENSITIVE download Created with Sketch. 215.69KB Share
(20min delay)
